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Abstract
Few microbial functions have been compared to a comprehensive survey of the human fecal microbiome. We evaluated
determinants of fecal microbial b-glucuronidase and b-glucosidase activities, focusing especially on associations with
microbial alpha and beta diversity and taxonomy. We enrolled 51 healthy volunteers (26 female, mean age 39) who
provided questionnaire data and multiple aliquots of a stool, from which proteins were extracted to quantify b-
glucuronidase and b-glucosidase activities, and DNA was extracted to amplify and pyrosequence 16S rRNA gene sequences
to classify and quantify microbiome diversity and taxonomy. Fecal b-glucuronidase was elevated with weight loss of at least
5 lb. (P=0.03), whereas b-glucosidase was marginally reduced in the four vegetarians (P=0.06). Both enzymes were
correlated directly with microbiome richness and alpha diversity measures, directly with the abundance of four Firmicutes
Clostridia genera, and inversely with the abundance of two other genera (Firmicutes Lactobacillales Streptococcus and
Bacteroidetes Rikenellaceae Alistipes) (all P=0.05–0.0001). Beta diversity reflected the taxonomic associations. These
observations suggest that these enzymatic functions are performed by particular taxa and that diversity indices may serve
as surrogates of bacterial functions. Independent validation and deeper understanding of these associations are needed,
particularly to characterize functions and pathways that may be amenable to manipulation.
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Introduction
The human intestinal microbial population is comprised of at
least a trillion bacterial cells per gram of feces. [1] Most of these
bacteria can be classified into 400–800 individual species, the
majority of which are only known by sequence analysis. [1,2] This
gut microbial reactor is in close balance with the human host as it
protects against pathogens, detoxifies potential poisons, produces
energy and nutrients by digestion of food and de novo synthesis,
conditions and maintains mucosal and systemic immunity, and
facilitates homeostasis. [3,4].
How the microbiota exerts these effects is starting to be
understood using modern sequencing approaches, with which the
genetic potential of a microbial community can be discerned. By
using these culture-independent methods, researchers have started
to obtain insight with respect to broad functional activities of the
intestinal microbiota. [5–7] Yet, the interrelationships of genomic
sequence analysis with specific bacterial functions and their role in
host homeostasis is still poorly defined, in part because
metagenomics only interrogates functional potential of a gene,
not gene expression. Global assessment of microbial functions is
not yet possible. However, advances can be made by studies of
selected microbial enzymatic activities that are highly relevant to
survival of the organism, as well as to disease in the human host.
Recent analysis of the gut microbiota using a deep sequencing
approach has identified b-glucuronidase as a conserved function
among bacteria colonizing the human gastrointestinal tract. [7] b-
glucuronidases are believed to be an important and critical
component in the cleavage of xenobiotic compounds and
conjugated hormones that, once free, can re-enter the human
body via enterohepatic circulation. The clinical relevance is that
sustained systemic hormone levels via b-glucuronidase activity
could contribute to hormone-sensitive pathologies such as the
increased risk of breast cancer in postmenopausal women who
have high endogenous estrogen levels. [8] On the other hand,
recent studies suggest a hormone-related protection of colorectal
cancer via enzymatic activation of phytoestrogens and other
compounds found in fish oil, cruciferous vegetables, and estrogens.
[9] b-glucosidases on the other hand, seem to have a more general
role in the bioavailability of plant polyphenols and the extraction
of energy from insoluble fibers and other indigestible carbohy-
drates. [10] Characterization of b-glucuronidases and b-glucosi-
dases have shown that these important functions are selectively
expressed by members of the gut microbiota and that diet
composition partially explains the induction of genes expressing
these enzymes. [11,12] This suggests that the gut microbiota is
a robust system that interconnects and is controlled by multiple
factors and at multiple levels. A better understanding of the role of
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microbial diversity is needed.
In this study of healthy volunteers, we correlate functional
activities of b-glucuronidase and b-glucosidase of the human gut
microbiota with measures of microbial diversity and taxonomy.
The goal is to identify microbial parameters that can provide
insight on human-microbe homeostasis and that might serve as
surrogates of bacterial functions.
Results
In specimens provided by 51 volunteers (26 female, mean age
39, range 17–65 years), fecal b-glucuronidase and b-glucosidase
activity levels were significantly correlated (R=0.60, P=0.0001).
The enzyme activity levels had few significant associations with
corresponding demographic or questionnaire parameters (Table 1).
b-glucuronidase was 2.3-fold (e
0.85) higher among participants who
reported having lost at least 5 lb body weight in the previous year
(P=0.03). Weight loss was not related to b-glucosidase level, and
neither enzyme was related to body mass index (BMI) overall. The
four vegetarians had 0.57-fold (e
20.56) lower b-glucosidase levels
(P=0.06). Although antibiotics and other prescription medications
used within the previous six months were strongly associated with
fecal microbiome alpha diversity, [13] they were not associated
with enzyme activities (Table 1).
In contrast to the questionnaire data, both enzymes were
directly and significantly correlated with four different measures of
microbial richness and alpha diversity, indicating higher enzyme
activity with higher microbial diversity (Table 2). Although all
were statistically significant, the enzyme activities were less
strongly associated with the alpha diversity measures that
standardize for multiple copies of the same OTU (i.e., Chao1
and Shannon) and more strongly with counts of observed species
(P=0.01 for b-glucuronidase, P=0.007 for b-glucosidase) and
with phylogenetic distance (PD) whole tree (P=0.002 for b-
glucuronidase, P=0.001 for b-glucosidase).
Principal component (PC) analysis on the sample similarity
matrix was used to derive 10 PC vectors as measurements of beta
diversity. These PCs explained very little of the variance.
Nonetheless, the first PC (7% of variance) and especially the
second PC (6% of variance), but none of the other PCs, were
significantly associated with reduced levels of both enzymes
(Table 2). The Shannon index was significantly reduced with the
second PC (R=20.71) but not with the first PC (R=20.08);
correlations with the other measures of alpha diversity were very
similar (Results not presented).
Turning to taxonomy, we examined 61 taxa with a mean
relative abundance $0.1%, including bacteria in 5 defined phyla,
55 genera, and an unclassified group. The activities of one or both
enzymes were associated with the relative abundance of eight
genera, but they were not associated with the two major or three
minor phyla (Table 2). Inverse associations, especially for b-
glucosidase, were found with the abundance of two Firmicutes,
Streptococcus and Roseburia. Activities of both enzymes were directly
associated with the abundance of Alistipes in the phylum
Bacteroidetes and also with the abundance of five Clostridia genera,
especially Ruminococcaceae, Subdoligranulum and non-Clostridiales
(Table 2). The taxa associated with high enzyme activities
appeared to be under-represented in the second PC (R=20.45
to 20.73).
Discussion
We examined how the activities of two fecal microbial enzymes
related to demographics of study participants, simple dietary
factors, antibiotics and other medications, and especially to
diversity and taxonomy of the distal human gut microbiome.
Our major finding was that the activities of both enzymes were
directly correlated with increased alpha diversity and especially
with increased richness of the fecal microbiome. This comple-
ments our finding that the enzyme activities were associated with
the abundance of a few relatively rare bacterial taxa, but not with
the abundance of the major bacterial phyla. Likewise, in our beta
diversity analysis, enzyme activities were significantly reduced in
two distinct microbial communities, one of which (PC2) was
sparsely populated with the high-enzyme activity taxa. Not
withstanding evidence of in vitro b-glucosidase activity of several
cultured strains of Firmicutes and Bifidobacteria in the phylum





Variable (units) Beta P-value Beta P-value
Gender (male=0, female=1) 0.32 0.22 0.20 0.22
Age (per year) 0.002 0.89 20.01 0.09
Body mass index [BMI (per Kg/M
2)]
b 20.03 0.49 20.04 0.10
BMI category (,25=0, $25=1) 20.05 0.81 20.19 0.24
Weight gain (no change=0, $5l b=1 ) 20.12 0.73 20.13 0.56
Weight loss (no change=0, $5l b=1) 0.85 0.03 0.28 0.26
Antibiotic use (,6 months=1, else=0) 20.09 0.77 20.19 0.30
Other prescription (,6 months=1, else=0) 0.04 0.89 20.03 0.86
Food allergy (no=0, yes=1) 0.43 0.32 0.09 0.73
Vegetarian (no=0, yes=1) 20.05 0.92 20.56 0.06
Probiotic supplement use (n=0, yes=1) 20.31 0.25 20.26 0.13
Ever smoker (no=0, yes=1) 0.60 0.09 20.04 0.84
aBeta values estimate the increase in loge of enzymatic activity (IU/100 mg fecal protein) per unit increase in the independent variable.
bBMI models were adjusted for gender and age.
doi:10.1371/journal.pone.0039745.t001
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b-glucosidase enzymatic functions in our participants were mostly
performed by particular genera rather than by the microbial
community at large.
Activities of both enzymes were directly associated with higher
abundance of five Clostridia genera in the phylum Firmicutes,
especially with Ruminococcaceae, Subdoligranulum and non-Clostri-
diales, largely complementing and corroborating in vitro results,
such as the previously noted high prevalence of the classical gus
gene and b-glucuronidase activity among Ruminococcaceae isolates.
[11,12,14,15] Comparison of our results to the in vitro studies is
difficult, but some differences should be noted. [7,11] We found
that activity levels of both enzymes had significant inverse
associations with the relative abundance of Roseburia, whereas
Dabek and colleagues noted that all eight Roseburia strains
examined produced b-glucosidase and six of these also produced
b-glucuronidase. [11] Moreover, Gloux et al found one Roseburia
strain that harbored a newly discovered class of genes with b-
glucuronidase (BG) activity. [7] Perhaps of interest, this class of
BG genes also was found in strains of Ruminococcaceae Subdoli-
granulum, [7] a genus for which relative abundance was directly
correlated with the activity levels of both enzymes in our study.
Enzyme activities in our study also were directly associated with
the abundance of Alistipes in the phylum Bacteroidetes, which did
not harbor the newly discovered BG genes, but which also has
not been evaluated for in vitro production of b-glucuronidase or
b-glucosidase. [11,12] GenBank notes that the complete genome
of Alistipes shahii WAL 8301 (Accession number FP929032), a gut
isolate, contains seven copies of a BG gene. Further annotation,
functional and metatranscriptomic approaches are clearly needed
to discern whether the enzymatic levels detected in vivo
correspond to a few highly active and readily inducible genes,
or to more modest expression by multiple glycosidase genes
acting in concert.









Chao1 0.008 0.04 0.005 0.04
Shannon 0.661 0.02 0.414 0.02
Observed species 0.014 0.01 0.009 0.007
Phylogenetic distance (PD) whole tree 0.249 0.002 0.155 0.001
Beta diversity measures
c
Principal component 1 22.54 0.029 21.75 0.012
Principal component 2 23.53 0.003 22.5 0.0005
Major phyla, selected genera (mean relative abundance)
Firmicutes (80.3%) 0.002 0.932 20.003 0.91
Firmicutes Lactobacillales
Streptococcaceae Streptococcus (0.5%) 20.2 0.04 20.41 0.008
Firmicutes Clostridia
non-Clostridiales (0.2%) 0.32 0.0001
d 0.42 0.005
Firmicutes Clostridia Clostridiales
Lachnospiraceae Roseburia (4.0%) 20.26 0.02 20.58 0.0001
d
Peptostreptococcaceae genus NA (0.2%) 0.1 0.32 0.35 0.03
Ruminococcaceae Oscillibacter (1.2%) 0.24 0.01 0.19 0.23
Ruminococcaceae Subdoligranulum (2.8%) 0.28 0.002 0.53 0.0001
Ruminococcaceae genus NA (4.4%) 0.15 0.04 0.23 0.05
Bacteroidetes (16.9%) 20.005 0.77 20.0009 0.98
Bacteroidetes Bacteroidales
Rikenellaceae Alistipes (0.6%) 0.3 0.003 0.56 0.0001
d
Actinobacteria (1.3%) 0.002 0.27 0.002 0.55
Proteobacteria (0.5%) 20.0002 0.78 20.0002 0.84
Fusobacteria (0.2%) 20.02 0.73 20.06 0.49
Unclassified bacteria (0.8%) 0.09 0.32 0.28 0.055
aLog values of enzymatic activity IU/100 mg fecal protein. the two significantly associated principal components, per unit increase in alpha diversity, per tertile for
Firmicutes and Bacteroidetes phyla, and per level (none, low, high) for the minor phyla, genera and unclassified bacteria.
bBeta values estimate the increase (or decrease for negative values) in loge of enzymatic activity for the two significantly associated principal components, per unit
increase in alpha diversity, per tertile for Firmicutes and Bacteroidetes phyla, and per level (none, low, high) for the minor phyla, genera and unclassified bacteria.
cPrincipal component analysis based on unweighted Unifrac, adjusted for sex and age.
dStatistically significant at P,0.05 with Bonferroni correction for 61 taxa with mean relative abundance $0.1% that were evaluated.
doi:10.1371/journal.pone.0039745.t002
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expressed in a variety of microorganisms. In cultured specimens,
Mroczynska and Libudzisz found that b-glucuronidase and b-
glucosidase were produced at higher levels by Lactobacillus than by
Enterococcus in fecal isolates that were obtained from people ages 1
to 80. [16] In environmental water specimens, b-glucuronidase
was produced by several unidentified isolated gram-negative
bacteria, by unidentified Bacillus species in the phylum Firmicutes,
and by Escherichia coli (E. coli). [17] Several other Proteobacteria
Enterobacteriaceae species, in addition to E. coli, can produce b-
glucuronidase. [18] In our study, enzyme activities were not
associated with E. coli, but this organism had a mean relative
abundance of only 0.001%. At the phylum level, neither
Proteobacteria nor Firmicutes correlated with the activities of b-
glucuronidase or b-glucosidase.
Only two associations with our demographic and questionnaire
data were noteworthy, perhaps suggesting that all human gut
microbiota require these enzymatic functions. Our four vegetar-
ians had lower b-glucosidase levels, resembling the observation of
Ling and Ha ¨nninen, who reported that activities of both b-
glucosidase and b-glucuronidase decreased within one week of
changing from an omnivorous to an uncooked vegan diet. [19]
Conversely, we noted significantly higher b-glucuronidase activity
in participants who had lost weight. This observation is in
agreement with a recent study reporting increase in b-glucuron-
idase activity in obese volunteers following a weight-loss diet. [12]
Koning and colleagues saw an immediate decline in fecal b-
glucuronidase activity during one week on amoxicillin, but this
activity normalized within two months. [20] Thus, our null
associations with antibiotic use within the previous six months are
not surprising.
The primary limitations of our study are its small size, cross-
sectional design, and lack of expression data or in vitro systems
to explore the regulation and determinants of microbial
enzymatic and other functions. It also was limited by the
possibility that relatively rare taxa were misclassified with the
Ribosomal Database Project due to sequencing errors, which
precluded taxonomic comparisons below the genus level.
Nonetheless, given the paucity of understanding, our study
makes a useful contribution by demonstrating that b-glucuron-
idase and b-glucosidase activities are directly correlated with
microbiome diversity and with particular genera. These findings
suggest that these important functions are primarily accom-
plished by specialist organisms rather than by the community as
a whole. If replicated and characterized in greater depth,
perhaps the number of observed species could serve as
a biomarker for these enzymatic functions, and ultimately
particular strains or pathways might be exploited to improve
health and reduce the risk of disease.
Methods
Participants and Ethics
We studied 51 employees of the Division of Cancer Epidemi-
ology and Genetics, National Cancer Institute (NCI) who were
recruited following approval by the NCI Special Studies In-
stitutional Review Board and with signed informed consent. There
were no exclusion criteria. In addition to collected specimens,
a brief questionnaire was administered to all participants to gather
general information on demographics, health, medication use and
disease conditions that may affect the gut microbiota.
Laboratory Methods
Specimen collection and assay methods are reported elsewhere.
[13,21] Briefly, from four fecal aliquots self-collected in RNAlater
using two devices [Polymedco OC-auto collection device and
Sarstedt fecal collection tube (Nu ¨mbrecht, Germany)], DNA was
extracted and amplified by PCR targeting the V1–V2 region of
the 16S rRNA gene. Pyrosequencing of the barcoded amplicons
yielded 1,270,073 raw reads that were edited, de-noised, and
assigned at 97% or greater similarity to a mean of 431 operational
taxonomic units (OTUs) per participant. [13] OTUs from the four
aliquots were averaged for the current analysis.
To assess an important function of the microbiota, deconjuga-
tion of glycosylated metabolites, b-glucuronidase and b-glucosi-
dase activities were determined in triplicate by colorimetric
enzyme kinetic assays in four replicates from the same stool that
were independently collected by each participant in phosphate
buffered saline. [21] These methods yielded highly reproducible
estimates of alpha diversity, beta diversity, classification into the
most abundant bacterial phyla, and functional activities of the two
microbial enzymes. [13,21] Because reproducibility of b-glucosi-
dase activity with the Polymedco device was significantly lower
than with the Sarstedt device, [21] the current analysis was
restricted to the activities with the two Sarstedt devices, each run
in triplicate, which were then averaged.
Statistical Analyses
Alpha diversity measurements of the OTUs were generated
with the QIIME pipeline (http://qiime.sourceforge.net). The
sample similarity matrix was produced using unweighted UniFrac
analysis in the QIIME pipeline. We then performed principal
component (PC) analysis on the sample similarity matrix and
derived 10 PC vectors as measurements of beta diversity. The
sequences were assigned to taxa with the Ribosomal Database
Project (RDP) naı ¨ve Bayesian classifier [22] and the Visualization
and Analysis of Microbial Population Structures (VAMPS, Marine
Biology Laboratories, Woods Hole, MA) pipeline.
Pearson’s correlation was used to assess the relationship between
the activities of the two enzymes. The relationship between the
two enzymatic activity levels and parameters of alpha diversity,
beta diversity, and the questionnaire data [age, sex, body mass
index (BMI), weight loss or gain, certain dietary characteristics,
and use of antibiotics or other prescription medications] was
estimated with Pearson’s correlation. Linear regression was used to
test the association of enzymatic activity levels (average across
triplicates with the paired Sarstedt devices, natural log-trans-
formed) with multiple measures of alpha diversity and with relative
abundance of 61 taxa, including phyla and selected genera
[restricted to relative abundance $0.1% and ordered as zero, low
(below median detected) and high (above median)]. Significance
was based on trend tests or two-sided categorical tests with
a=0.05. Taxonomic associations with either enzyme that had
nominal P#0.05 are presented. Bonferroni was used to correct for
61 multiple comparisons.
Acknowledgments
We are grateful to the study participants and lab personnel.
Author Contributions
Conceived and designed the experiments: RF JJG. Performed the
experiments: RF JR. Analyzed the data: JS MHG PG. Contributed
reagents/materials/analysis tools: JR. Wrote the paper: RF JJG.
Fecal Microbiome and Selected Enzyme Functions
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e39745References
1. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. (2006)
Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–
1359. doi:10.1126/science.1124234.
2. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. (2010) A human gut
microbial gene catalogue established by metagenomic sequencing. Nature 464:
59–65. doi:10.1038/nature08821.
3. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI (2011) Human
nutrition, the gut microbiome and the immune system. Nature 474: 327–336.
doi:10.1038/nature10213.
4. Relman DA (2011) Microbial genomics and infectious diseases. N Engl J Med
365: 347–357. doi:10.1056/NEJMra1003071.
5. Zhu B, Wang X, Li L (2010) Human gut microbiome: the second genome of
human body. Protein Cell 1: 718–725. doi:10.1007/s13238-010-0093-z.
6. Turnbaugh PJ, Henrissat B, Gordon JI (2010) Viewing the human microbiome
through three-dimensional glasses: integrating structural and functional studies
to better define the properties of myriad carbohydrate-active enzymes. Acta
Crystallogr Sect F Struct Biol Cryst Commun 66: 1261–1264. doi:10.1107/
S1744309110029088.
7. Gloux K, Berteau O, El OH, Beguet F, Leclerc M, et al. (2011) A metagenomic
beta-glucuronidase uncovers a core adaptive function of the human intestinal
microbiome. Proc Natl Acad Sci U S A 108 Suppl 1: 4539–4546. doi:10.1073/
pnas.1000066107.
8. Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, et al. (2011)
Circulating sex hormones and breast cancer risk factors in postmenopausal
women: reanalysis of 13 studies. Br J Cancer 105: 709–722. doi:10.1038/
bjc.2011.254.
9. Barone M, Lofano K, De TN, Licino R, Albano F, et al. (2012) Dietary,
endocrine, and metabolic factors in the development of colorectal cancer. J
Gastrointest Cancer 43: 13–19. doi:10.1007/s12029-011-9332-7.
10. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols:
food sources and bioavailability. Am J Clin Nutr 79: 727–747.
11. Dabek M, McCrae SI, Stevens VJ, Duncan SH, Louis P (2008) Distribution of
beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene
gus in human colonic bacteria. FEMS Microbiol Ecol 66: 487–495.
doi:10.1111/j.1574-6941.2008.00520.x.
12. McIntosh FM, Maison N, Holtrop G, Young P, Stevens VJ, et al. (2012)
Phylogenetic distribution of genes encoding beta-glucuronidase activity in
human colonic bacteria and the impact of diet on faecal glycosidase activities.
Environ Microbiol. doi:10.1111/j.1462-2920.2012.02711.x.
13. Flores R, Shi J, Gail MH, Gajer P, Ravel J, et al. (2012) Assessment of the
human faecal microbiota: II. Reproducibility and associations of 16S rRNA
pyrosequences. Eur J Clin Invest. doi:10.1111/j.1365-2362.2012.02659.x.
14. Cole CB, Fuller R, Mallet AK, Rowland IR (1985) The influence of the host on
expression of intestinal microbial enzyme activities involved in metabolism of
foreign compounds. J Appl Bacteriol 59: 549–553.
15. Nakamura J, Kubota Y, Miyaoka M, Saitoh T, Mizuno F, et al. (2002)
Comparison of four microbial enzymes in Clostridia and Bacteroides isolated
from human feces. Microbiol Immunol 46: 487–490.
16. Mroczynska M, Libudzisz Z (2010) Beta-glucuronidase and beta-glucosidase
activity of Lactobacillus and Enterococcus isolated from human feces.
Pol J Microbiol 59: 265–269.
17. Tryland I, Fiksdal L (1998) Enzyme characteristics of beta-D-galactosidase- and
beta-D-glucuronidase-positive bacteria and their interference in rapid methods
for detection of waterborne coliforms and Escherichia coli. Appl Environ
Microbiol 64: 1018–1023.
18. Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, et al. (2008) Faecal
microflora and beta-glucuronidase expression are altered in an irinotecan-
induced diarrhea model in rats. Cancer Biol Ther 7: 1919–1925.
19. Ling WH, Hanninen O (1992) Shifting from a conventional diet to an uncooked
vegan diet reversibly alters fecal hydrolytic activities in humans. J Nutr 122: 924–
930.
20. Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, et al.
(2008) The effect of a multispecies probiotic on the intestinal microbiota and
bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J
Gastroenterol 103: 178–189. doi:10.1111/j.1572-0241.2007.01547.x.
21. Flores R, Shi J, Gail MH, Ravel J, Goedert JJ (2012) Assessment of the human
faecal microbiota: I. Measurement and reproducibility of selected enzymatic
activities. Eur J Clin Invest. doi:10.1111/j.1365-2362.2012.02660.x.
22. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, et al. (2009) The Ribosomal
Database Project: improved alignments and new tools for rRNA analysis.
Nucleic Acids Res 37: D141–D145. doi:10.1093/nar/gkn879.
Fecal Microbiome and Selected Enzyme Functions
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39745